5
Participants
Start Date
August 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Somatuline Autogel® (lanreotide) 60, 90, 120 mg.
Patients receiving treatment as prescribed by the investigator and according to current treatment recommendations and routine clinical practice, and in line with local regulations.
St Vincent's Hospital, Darlinghurst
Royal North Shore Hospital, St Leonards
St Vincent's Hospital, Fitzroy
The Austin Hospital, Heidelberg
Royal Brisbane & Women's Hospital, Herston
Princess Alexandra Hospital, Woolloongabba
Lead Sponsor
Ipsen
INDUSTRY